Marshall Wace, LLP Bausch & Lomb Corp Transaction History
Marshall Wace, LLP
- $77.3 Billion
- Q3 2024
A detailed history of Marshall Wace, LLP transactions in Bausch & Lomb Corp stock. As of the latest transaction made, Marshall Wace, LLP holds 463,622 shares of BLCO stock, worth $9.05 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
463,622
Previous 131,624
252.23%
Holding current value
$9.05 Million
Previous $1.91 Million
367.97%
% of portfolio
0.01%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding BLCO
# of Institutions
114Shares Held
37.5MCall Options Held
116KPut Options Held
173K-
Maple Rock Capital Partners Inc. Toronto, A63.62MShares$70.6 Million2.04% of portfolio
-
Icahn Carl C Sunny Isles Beach, FL3.5MShares$68.3 Million0.69% of portfolio
-
Goldentree Asset Management LP New York, NY3.36MShares$65.5 Million5.89% of portfolio
-
Alberta Investment Management Corp Edmonton, A02.21MShares$43.2 Million0.42% of portfolio
-
River Road Asset Management, LLC2.02MShares$39.4 Million0.54% of portfolio
About Bausch & Lomb Corp
- Ticker BLCO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 350,000,000
- Market Cap $6.83B
- Description
- Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replace...